Narrow search
Showing 1 - 10 of 1,297
Cover Image
International Health Economics
Egan, Mark - 2013
medical innovations whose returns are earned worldwide. Because world returns drive innovation and innovation is central to … countries. This paper analyzes the unique positive and normative implications of these innovation-induced linkages across … countries when governments centrally price health care. Providing world returns to medical innovation under such central pricing …
Persistent link: https://www.econbiz.de/10012459381
Cover Image
Health care issues in the United States and Japan
Wise, David A. (ed.); Yashiro, Naohiro (contributor) - 2006
Persistent link: https://www.econbiz.de/10003212049
Cover Image
Themes in the economics of aging
Wise, David A. (ed.) - 2001
Persistent link: https://www.econbiz.de/10001570013
Cover Image
Inquiries in the economics of aging
Wise, David A. (ed.) - 1998
Persistent link: https://www.econbiz.de/10013480942
Cover Image
Investigations in the economics of aging
Wise, David A. (ed.) - 2012
Financing retirement -- Were they prepared for retirement? : financial status at advanced ages in the HRS and AHEAD cohorts / James M. Poterba, Steven F. Venti, and David A. Wise ; comment, David Laibson -- Economic preparation for retirement / Michael D. Hurd and Susann Rohwedder ; comment,...
Persistent link: https://www.econbiz.de/10009724926
Cover Image
Health Care Financing, Efficiency, and Equity
Glied, Sherry A. - 2008
This paper examines the efficiency and equity implications of alternative health care system financing strategies. Using data across the OECD, I find that almost all financing choices are compatible with efficiency in the delivery of health care, and that there has been no consistent and...
Persistent link: https://www.econbiz.de/10012464766
Cover Image
Financing Vaccines for Global Health Security
Vu, Jonathan T. - 2020
Recent outbreaks of infectious pathogens such as Zika, Ebola, and COVID-19 have underscored the need for the dependable availability of vaccines against emerging infectious diseases (EIDs). The cost and risk of R&D programs and uniquely unpredictable demand for EID vaccines have discouraged...
Persistent link: https://www.econbiz.de/10012481795
Cover Image
High-Priced Drugs in Medicare Part D : Diagnosis and Potential Prescription
Frank, Richard G. - 2018
that supra competitive prices are necessary to promote innovation; significant disagreements arise over how much pricing … quality of drugs brought to market. It is grounded in the economics of two part tariffs, research on innovation prizes …
Persistent link: https://www.econbiz.de/10012453473
Cover Image
The Regulation of Prescription Drug Competition and Market Responses : Patterns in Prices and Sales Following Loss of Exclusivity
Aitken, Murray L. - 2013
We examine six molecules facing initial loss of US exclusivity (LOE, from patent expiration or challenges) between June 2009 and May 2013 that were among the 50 most prescribed molecules in May 2013. We examine prices per day of therapy (from the perspective of average revenue received by retail...
Persistent link: https://www.econbiz.de/10012459174
Cover Image
The Effect of Drug Vintage on Survival : Micro Evidence from Puerto Rico's Medicaid Program
Lichtenberg, Frank R. - 2004
Using micro data on virtually all of the drugs and diseases of over 500,000 people enrolled in Puerto Rico's Medicaid program, we examine the impact of the vintage (original FDA approval year) of drugs used to treat a patient on the patient's 3-year probability of survival, controlling for...
Persistent link: https://www.econbiz.de/10012467803